thymoquinone has been researched along with Cancer of Cervix in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Masum, A; Kazi, M; Khan, JH; Khan, MA; Shariare, MH; Uddin, J | 1 |
| Cho, GJ; Choi, MY; Choi, WS; Kim, MJ; Kim, YS; Lee, HJ | 1 |
| Chen, H; Cheng, J; Fu, J; Ijaz, I; Khan, MA; Li, J; Wei, C; Yang, L | 1 |
| Al-Ani, IM; Bilal, HG; Ichwan, SJ; Ikeda, MA; Suriyah, WH; Taher, M | 1 |
| Shin, SB; Woo, SU; Yim, H | 1 |
| Ismail, M; Ng, WK; Yazan, LS | 1 |
| Benghuzzi, H; Brewer, J; Tucci, M | 1 |
7 other study(ies) available for thymoquinone and Cancer of Cervix
| Article | Year |
|---|---|
Development of Stable Liposomal Drug Delivery System of Thymoquinone and Its In Vitro Anticancer Studies Using Breast Cancer and Cervical Cancer Cell Lines.
Topics: Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Liposomes; Particle Size; Phospholipids; Uterine Cervical Neoplasms | 2022 |
UHRF1 silences gelsolin to inhibit cell death in early stage cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Benzoquinones; CCAAT-Enhancer-Binding Proteins; Cell Cycle Checkpoints; Cell Death; Cyclin-Dependent Kinase Inhibitor p27; Female; Gelsolin; Gene Knockdown Techniques; Gene Silencing; Humans; Middle Aged; Neoplasm Staging; Papillomavirus E7 Proteins; Poly(ADP-ribose) Polymerases; Ubiquitin-Protein Ligases; Uterine Cervical Neoplasms | 2020 |
Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1.
Topics: Apoptosis; Benzoquinones; Blotting, Western; Cell Line, Tumor; Cell Survival; Epithelial-Mesenchymal Transition; Female; Humans; Nuclear Proteins; Twist-Related Protein 1; Uterine Cervical Neoplasms; Zinc Finger E-box-Binding Homeobox 1 | 2017 |
Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Female; Humans; Nigella sativa; Seeds; Signal Transduction; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2014 |
Differential Cellular Effects of Plk1 Inhibitors Targeting the ATP-binding Domain or Polo-box Domain.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Benzimidazoles; Benzoates; Benzoquinones; Binding Sites; Catalytic Domain; Cell Cycle Proteins; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Design; Female; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Inhibitory Concentration 50; Mitosis; Molecular Targeted Therapy; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Pteridines; Quinones; S Phase Cell Cycle Checkpoints; Signal Transduction; Thiophenes; Time Factors; Uterine Cervical Neoplasms | 2015 |
Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Carcinoma, Squamous Cell; Cell Line, Tumor; Chlorocebus aethiops; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Mice; Nigella sativa; Proto-Oncogene Proteins c-bcl-2; Uterine Cervical Neoplasms; Vero Cells | 2011 |
Effects of thymoquinone, lycopene, and selenomethione in the presence of estrogen on the viability of SiHa cells in vitro.
Topics: Antineoplastic Agents; Antioxidants; Benzoquinones; Carcinoma, Squamous Cell; Carotenoids; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Estrogens; Female; Humans; Lycopene; Selenomethionine; Uterine Cervical Neoplasms | 2006 |